Bridgewater Associates LP Decreases Stock Holdings in Teleflex Incorporated (NYSE:TFX)

Bridgewater Associates LP lessened its holdings in shares of Teleflex Incorporated (NYSE:TFX - Free Report) by 30.7% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 5,256 shares of the medical technology company's stock after selling 2,330 shares during the quarter. Bridgewater Associates LP's holdings in Teleflex were worth $935,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Headlands Technologies LLC purchased a new stake in Teleflex in the fourth quarter valued at $29,000. Avior Wealth Management LLC lifted its stake in Teleflex by 81.2% during the 4th quarter. Avior Wealth Management LLC now owns 279 shares of the medical technology company's stock worth $50,000 after acquiring an additional 125 shares in the last quarter. IFP Advisors Inc boosted its holdings in Teleflex by 238.5% during the 4th quarter. IFP Advisors Inc now owns 308 shares of the medical technology company's stock valued at $55,000 after acquiring an additional 217 shares during the period. Exchange Traded Concepts LLC grew its position in Teleflex by 38.2% in the 4th quarter. Exchange Traded Concepts LLC now owns 340 shares of the medical technology company's stock valued at $61,000 after acquiring an additional 94 shares in the last quarter. Finally, R Squared Ltd acquired a new position in Teleflex in the 4th quarter valued at about $64,000. Institutional investors and hedge funds own 95.62% of the company's stock.

Teleflex Price Performance

TFX traded up $1.96 during midday trading on Thursday, reaching $134.98. 93,755 shares of the company's stock were exchanged, compared to its average volume of 625,359. The company has a debt-to-equity ratio of 0.37, a current ratio of 2.42 and a quick ratio of 1.39. The stock has a market capitalization of $6.26 billion, a PE ratio of 26.83, a P/E/G ratio of 1.73 and a beta of 1.19. The business's 50-day moving average price is $141.49 and its 200 day moving average price is $175.69. Teleflex Incorporated has a 1-year low of $124.66 and a 1-year high of $249.91.

Teleflex (NYSE:TFX - Get Free Report) last issued its quarterly earnings results on Thursday, February 27th. The medical technology company reported $3.89 EPS for the quarter, topping analysts' consensus estimates of $3.86 by $0.03. The business had revenue of $795.40 million during the quarter, compared to the consensus estimate of $813.24 million. Teleflex had a net margin of 7.85% and a return on equity of 14.19%. As a group, equities analysts anticipate that Teleflex Incorporated will post 13.98 EPS for the current fiscal year.

Teleflex Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Monday, March 17th. Investors of record on Friday, March 7th were issued a $0.34 dividend. The ex-dividend date was Friday, March 7th. This represents a $1.36 dividend on an annualized basis and a yield of 1.01%. Teleflex's payout ratio is 95.77%.

Wall Street Analyst Weigh In

TFX has been the subject of several research reports. Wells Fargo & Company dropped their target price on Teleflex from $214.00 to $146.00 and set an "equal weight" rating for the company in a research report on Friday, February 28th. Bank of America downgraded Teleflex from a "neutral" rating to an "underperform" rating and dropped their target price for the company from $235.00 to $140.00 in a research report on Tuesday, March 4th. StockNews.com downgraded Teleflex from a "buy" rating to a "hold" rating in a research report on Friday, February 28th. Morgan Stanley dropped their target price on Teleflex from $275.00 to $191.00 and set an "overweight" rating for the company in a research report on Wednesday, March 5th. Finally, Truist Financial decreased their price objective on Teleflex from $149.00 to $140.00 and set a "hold" rating for the company in a research note on Friday, April 11th. One investment analyst has rated the stock with a sell rating, nine have given a hold rating and two have given a buy rating to the company's stock. Based on data from MarketBeat, Teleflex has a consensus rating of "Hold" and an average price target of $169.63.

Teleflex Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.